PCG
67
-2
CNP
55
-2
RSG
50
-4
MCHP
45
-4
NOV
47
-6
LB
22
-7
IBM
62
-3
PLD
40
-8
NAVI
40
5
EXPD
35
-2
UHS
60
-2
SIG
52
5
EXR
22
-6
VLO
48
-2
FOX
60
-10
KMI
53
-6
BDX
60
-4
COP
40
-2
AXP
71
-3
KIM
51
-3
PCG
67
-2
CNP
55
-2
RSG
50
-4
MCHP
45
-4
NOV
47
-6
LB
22
-7
IBM
62
-3
PLD
40
-8
NAVI
40
5
EXPD
35
-2
UHS
60
-2
SIG
52
5
EXR
22
-6
VLO
48
-2
FOX
60
-10
KMI
53
-6
BDX
60
-4
COP
40
-2
AXP
71
-3
KIM
51
-3
Financhill
Back

SPDR S&P Global Natural Resources ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
33

GNR
SPDR S&P Global Natural Resources ETF

Last Price:
$61.79
Seasonality Move:
1.06%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.95
Seasonality Move:
11.58%
Sell
33
SPDR S&P Global Natural Resources ETF (GNR) is a Sell

Is SPDR S&P Global Natural Resources ETF a Buy, Sell or Hold?

  • The current SPDR S&P Global Natural Resources ETF [GNR] share price is $61.30. The Score for GNR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • GNR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GNR Stock Price Chart

What is SPDR S&P Global Natural Resources ETF's stock price today?

  • The SPDR S&P Global Natural Resources ETF share price today is $61.30
    The current trend is moderately bullish and GNR is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

GNR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.71 Buy
Relative Strength Index (14 RSI): 54.2 Buy
Chaikin Money Flow: -159935 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GNR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.72 Sell
20-day SMA: 60.78 Buy
50-day SMA: 59.79 Buy
200-day SMA: 55.83 Buy
8-day EMA: 61.69 Sell
20-day EMA: 61.05 Buy
50-day EMA: 58.91 Buy
200-day EMA: 36.89 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

SPDR S&P Global Natural Resources ETF Earnings Growth & GNR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

SPDR S&P Global Natural Resources ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):